Intragastric Balloons in the Management of Obesity
Publication Date: March 31, 2021
Key Points
Key Points
- Obesity is a global pandemic, affecting about 40% of adults in the United States.
- Fewer than 5% of patients with obesity seeking a weight loss therapy are aware of endoscopic weight loss options.
- Multiple new devices have recently been introduced into the U.S. market
Treatment
Treatment
...dividuals with obesity seeking a weight-loss inter...
...s with obesity undergoing IGB ther...
...ndividuals undergoing IGB therapy, AGA recommen...
...dividuals undergoing IGB therapy, AGA suggest...
...In individuals undergoing IGB therapy, AGA sugg...
...daily supplementation with 1–2 adult dose...
...removal, AGA suggests subsequent weight-loss...